| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 32.42B | 31.62B | 34.83B | 31.69B | 30.36B |
| Gross Profit | 13.62B | 18.80B | 19.88B | 20.24B | 19.44B |
| EBITDA | 19.84B | 18.86B | 21.91B | 20.29B | 19.60B |
| Net Income | 14.31B | 14.16B | 17.47B | 15.58B | 15.00B |
Balance Sheet | |||||
| Total Assets | 561.23B | 560.21B | 568.92B | 561.68B | 566.26B |
| Cash, Cash Equivalents and Short-Term Investments | 21.21B | 16.84B | 21.37B | 18.68B | 15.99B |
| Total Debt | 264.85B | 264.85B | 265.85B | 260.35B | 260.35B |
| Total Liabilities | 293.42B | 292.43B | 294.12B | 286.78B | 287.54B |
| Stockholders Equity | 267.81B | 267.78B | 274.80B | 274.91B | 278.72B |
Cash Flow | |||||
| Free Cash Flow | 15.16B | 18.42B | 14.61B | 23.47B | -22.48B |
| Operating Cash Flow | 18.11B | 21.63B | 62.48B | 24.49B | 29.75B |
| Investing Cash Flow | -3.56B | -3.26B | -46.75B | -2.55B | -50.45B |
| Financing Cash Flow | -14.72B | -22.54B | -12.37B | -19.81B | 23.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥167.39B | 6.57 | ― | 4.70% | 50.47% | 26.45% | |
73 Outperform | ¥668.49B | 10.14 | 5.51% | 4.64% | 24.10% | -30.38% | |
67 Neutral | ¥344.57B | 23.38 | 5.35% | 4.18% | -5.01% | ― | |
66 Neutral | ¥404.42B | 21.18 | 7.08% | 3.74% | 78.62% | 28.76% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥564.16B | 23.41 | 6.80% | 4.46% | 52.74% | 14.88% | |
62 Neutral | ¥194.77B | 9.62 | 7.82% | 3.87% | 21.72% | 5.02% |